This inventor holds 2 USPTO granted patents. Top assignees: Apitbio, Inc, Kangwon National University University-Industry Cooperation Foundation. Active years: 2024-2025.
Company Filing History:
1 out of 1 
1 out of 24 Years Active: 2024-2025
Title: Heesu Chae: Innovator in Antibody Development
Introduction
Heesu Chae is a prominent inventor based in Seoul, South Korea. He is known for his significant contributions to the field of biotechnology, particularly in the development of antibodies that target specific proteins involved in tumor progression.
Latest Patents
Heesu Chae holds a patent for "Anti-L1CAM antibodies and uses thereof." This patent provides antibodies that specifically bind to L1CAM, along with compositions that include these antibodies. The invention also outlines methods for preventing or treating diseases or conditions that involve tumors using the anti-L1CAM antibodies. He has 1 patent to his name.
Career Highlights
Heesu Chae is currently employed at Apitbio, Inc., where he continues to advance his research in antibody development. His work is crucial in the ongoing fight against cancer and other related diseases.
Collaborations
Heesu collaborates with talented individuals such as Hyo Jeong Hong and Jisu Hong, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Heesu Chae's work in developing anti-L1CAM antibodies represents a significant advancement in therapeutic strategies for cancer treatment. His contributions to biotechnology are paving the way for future innovations in the field.